Irradiated Riboflavin Diminishes the Aggressiveness of Melanoma In Vitro and In Vivo

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Machado, Daisy ^a   Shishido, Silvia M ^a   Queiroz, Karla C S ^b   Oliveira, Diogo N ^a   Faria, Ana L C ^a   Catharino, Rodrigo R ^a   Spek, C Arnold ^b   Ferreira, Carmen V ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PROTEIN; CYCLOPAMINE; GANT 61; IRRADIATED RIBOFLAVIN; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE; PROTEIN PATCHED; PROTEIN SUFU; PROTEIN TYROSINE KINASE; RIBOFLAVIN; RIBOFLAVIN DERIVATIVE; SONIC HEDGEHOG PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR GLI1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MALE; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FLAVINS; HUMANS; KERATINOCYTES; MALE; MELANOMA; MICE; MICE, INBRED C57BL; PYRIDINES; PYRIMIDINES; RIBOFLAVIN; VERATRUM ALKALOIDS;

ERINACEIDAE; MURINAE;

EID: 84872469432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054269     Document Type: Article

References (65)

1. Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ, (2000) Early detection and treatment of skin cancer. Am Fam Physician 62: 357-368.
2. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, et al. (2012) Cancer treatment and survivorship statistics, 2012. Cancer J Clin 62(4): 220-41.
3. Tas F (2012) Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors. J Oncol 10.1155/2012/647684.
4. Martí RM, Sorolla A, Yeramian A (2012) New therapeutic targets in melanoma. Actas Dermosifiliogr "In press".
5. Lutzky J, (2010) New therapeutic options in the medical management of advanced melanoma. Semin Cutan Med Surg. 29: 249-257.
6. Chaffer CL, Weinberg RA, (2011) A Perspective on Cancer Cell Metastasis. Science 1559: 331.
7. Joyce JA, Pollard JW, (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(4): 239-52.
8. Hofmann UB, Westphal JR, van Muijen GNP, Ruiter DJ, (2000) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115(3): 337-344.
9. LeBleu VX, MacDonald B, Kalluri R, (2007) Structure and function of basement membranes. Exp Biol Med 232: 1121-1129.
10. Nagase H, Visse R, Murphy G, (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573.
11. Roy R, Yang J, Moses MA, (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287-5297.
12. Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, et al. (2009) Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res 39: 177-186.
13. Liu L, Li F, Cardelli JA, Martin KA, Blenis J, et al. (2006) Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene. 25: 7029-7040.
14. Jazirehi AL, Wenn PB, Damavand M, (2012) Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapy. Am J Cancer Res 2(2): 178-191.
15. Meier F, Schittek B, Busch S, Garb C, Smalley K, et al. (2005) The RAS/RAF/MEK/ERKand PI3K/AKT signaling pathways present molecular targets for effective treatment of advanced melanoma. Frontiers Biosc 10: 2986-3001.
16. Stahl JM, Sharma A, Cheung M, Zimmerman M, Cheng JQ, et al. (2004) Deregulated AKT3 activity promotes development of malignant melanoma. Cancer Res 64: 7002-7010.
17. Sarbassov DD, Ali SM, Sabatini DM, (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17: 596-603.
18. Zhou H, Huang S, (2011) Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr Protein Pept Sci 12(1): 30-42.
19. Guertin DA, Sabatini DM, (2007) Defining the Role of mTOR in Cancer. Cancer Cell 12: 9-22.
20. Sen B, Johnson FM, (2011) Regulation of SRC family kinase in human cancers. J Signal Transduct 2011: 1-14.
21. Ferguson J, Arozarena I, Ehrhardt M, Wellbrock C (2012) Combination of MEK and Src inhibition suppresses melanoma cell growth and invasion. Oncogene 10.1038/onc.2012.25.
22. Liao X, Siu MKY, Au CWH, Wong ES, Chan HY, et al. (2009) Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30: 131-40.
23. Hsieh A, Ellsworth R, Hsieh D, (2011) Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol 226: 1118-27.
24. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, et al. (2007) Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67: 2187-96.
25. Souzaki M, Kubo M, Kai M, Kameda C, Tanaka H, et al. (2011) Hedgehog signaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer. Cancer Sci 102: 373-81.
26. Kar S, Deb M, Sengupta D, Shilpi A, Bhutia SK, et al. (2012) Intricacies of hedgehog signaling pathways: a perspective in tumorigenesis. Exp Cell Res 318(16): 1959-1972.
27. Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, et al. (2002) Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem 277: 5548-55.
28. Pola R, Ling LE, Silver M, Corbley MJ, Kearney M, et al. (2001) The morphogen Sonic hedgehog is an indirect angiogenic agent upregulatins two families of angiogenic growth factors. Nat Med 7: 706-711.
29. Das S, Harris LG, Metge BJ, Liu S, Riker AI, et al. (2009) The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J Biol Chem 284: 22888-97.
30. Stecca B, Mas C, Clement C, Zbinden M, Correa R, et al. (2007) Melanomas require Hedgehog-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. PNAS 104(14): 5895-5900.
31. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, et al. (2008) Toxicity testing of a novel riboflavin-based techonology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 22(2): 133-53.
32. Massey V, (2000) The chemical and biological versatility of riboflavin. Biochem Soc Trans 28: 283-96.
33. Ahmad I, Fasihyllah Q, Noor A, Ansari IA, Ali QNM, (2004) Photolysis of riboflavin in aqueous solution: a kinetic study. Int J PharM 280: 199-208.
34. de Souza Queiroz KC, Zambuzzi WF, Santos de Souza AC, da Silva RA, Machado D, et al. (2007) A possible anti-proliferative and anti-metastaic effect of irradiated riboflavin in solid tumors. Cancer Lett 258: 126-34.
35. Ohkawa H, Ohishi N, Yagi K, (1983) New metabolites of riboflavin appear in human urine. J Biol Chem 258: 5623-28.
36. Chastain J, McCormick B, (1987) Clarification and quantitation of primary (tissue) and secondary (microbial) catabolites of riboflavin that are excreted in mammalian (rat) urine. J Nutr 117: 468-75.
37. de Souza AC, Kodach L, Gadelha FR, Bos CL, Cavagis AD, et al. (2006) A promising action of riboflavin as a mediator of leukaemia cell death. Apoptosis 11: 1761-71.
38. Erve JCL, DeMaio W, Tallat RE, (2008) Rapid metabolite identification with sub parts-per-million mass accuracy from biological matrices by direct infusion nanoelectrospray ionization after clean-up on a ZipTip and LTQ/Orbitrap mass spectrometry. Rapid Commun Mass Spectrom 22(19): 3015-3026.
39. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 65: 55-63.
40. Bijlsma MF, Borensztajn KS, Roelink H, Peppelenbosch MP, Spek CA, (2007) Sonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolites. Cell Signal 19(12): 2596-604.
41. Borensztajn K, Stiekema J, Nijmeeijer S, Reitsma PH, Peppelenbosch MP, et al. (2008) Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol 172(2): 309-320.
42. Souza AP, Gerlach RF, Line SR, (2000) Inhibition of human gingival gelatinases (MMP-2 and MMP-9) by metal salts. Dental Mater 16(2): 103-108.
43. Bruggemann LW, Versteeg HH, Reitsma PH, Spek CA, (2008) High factor VIIa levels do not promote tumor metastasis. Tromb Haemost 99: 787-788.
44. Bruggemann LW, Versteeg HH, Niers TM, Reitsma PH, Spek CA, (2008) Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med 12: 2622-2627.
45. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
46. Van Sluis GL, Niers TM, Esmon CT, Tigchelaar W, Richel DJ, et al. (2009) Endogenous activated protein C limits vancer cell extravasation through sphingosine-1-phosphate receptor 1-mediates vascular endothelial barrier enhancement. Blood 114: 1968-1973.
47. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, et al. (2008) Toxicity testing of a novel riboflavin-based techonology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 22(2): 133-153.
48. Eubanks LM, Dickerson TJ, Janda KD, (2005) Vitamin B2 mediated cellular photoinhibition of botulinum neurotoxin A. FEBS Lett. 579: 5361-64.
49. Wollensak G, Aurich H, Pham DT, Wirbelauer C, (2007) Hydratin behavior of porcine cornea crosslinkedwiht riboflavin and ultraviolet A. J Cataract Refract Surg. 33: 516-21.
50. Gkika M, Labiris G, Kozobolis V, (2011) Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies. Int Ophthalmol 31(4): 309-19.
51. Chaves Neto AH, Yano CL, Paredes-Gamero EJ, Machado D, Justo GZ, et al. (2010) Riboflavin and photoproducts in MC3T3-E1 differentiation. Toxicol In Vitro 24(7): 1911-1919.
52. Xiao L, Wang YC, Li WS, Du Y, (2009) The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray. J Exp Clin Cancer Res 28: 152.
53. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, et al. (2012) The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485(7396): 55-61.
54. Li C, Narayanan R, Lu Y, Hurh E, Coss CC, et al. (2010) 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5′-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways. Int J Oncol 37: 1023-30.
55. Anvekar RA, Asciolla JJ, Missert DJ, Chipuk JE, (2011) Born to be alive: a role for the BCL-2 family in melanoma tumor cell survival, apoptosis, and treatment. Fron Oncol 1: 34.
56. Chen Y, Chen Y, Huang L, Yu J, (2012) Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma. J Dermatol 39(4): 339-343.
57. Lum L, Beachy PA, (2004) The hedgehog response network: sensors, switches, and routers. Science 304(5678): 1755-1759.
58. Carpenter RL, Lo HW, (2012) Hedgehog pathway and GLI1 isoforms in human cancer. Discov Med 13(69): 105-113.
59. Fan H, Khavari PA, (1999) Sonic hedgehog opposes epithelial cell cycle arrest. J Cell Biol 147: 71-76.
60. Green CL, Khavari PA, (2004) Targets for molecular therapy of skin cancer. Sem Cancer Biol 14: 63-69.
61. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, et al. (2000) Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 24(3): 216-17.
62. van den Brink GR, (2007) Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol Rev 87(4): 1343-1375.
63. Tukachinsky H, Lopez LV, Salic A, (2010) A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes. J Cell Biol 191(2): 415-28.
64. Svärd J, Heby-Henricson K, Persson-Lek M, Rozell B, Lauth M, et al. (2006) Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell 10: 187-197.
65. Jia J, Kolterud A, Zeng H, Hoover A, Teglund S, et al. (2009) Suppressor of Fused inhibits mammalian Hedgehog signaling in the absence of cilia. Dev Biol 330(2): pp. 452-460.